These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The treatment of familial erythrophagocytic lymphohistiocytosis. Lilleyman JS Cancer; 1980 Aug; 46(3):468-70. PubMed ID: 6893166 [TBL] [Abstract][Full Text] [Related]
11. [Etoposide (VP 16/NK 171) and cytosine arabinoside combination chemotherapy in refractory childhood leukemia]. Esumi N; Todo S; Arakawa S; Imashuku S Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):951-8. PubMed ID: 3963859 [TBL] [Abstract][Full Text] [Related]
12. VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features. Hurd DD; Peterson BA; McKenna RW; Bloomfield CD Med Pediatr Oncol; 1981; 9(3):251-5. PubMed ID: 7017368 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer. Eagan RT; Ahmann DL; Bisel HF Oncology; 1976; 33(3):146-8. PubMed ID: 1012648 [TBL] [Abstract][Full Text] [Related]
17. Familial erythrophagocytic lymphohistiocytosis: late relapse despite continuous high-dose VP-16 chemotherapy. Ware R; Friedman HS; Kinney TR; Kurtzberg J; Chaffee S; Falletta JM Med Pediatr Oncol; 1990; 18(1):27-9. PubMed ID: 2294389 [No Abstract] [Full Text] [Related]
18. Oral VP-16-213 in advanced bronchogenic carcinoma and toxic effects when combined with methotrexate. Anderson G; Bowyer F; Williams L Thorax; 1981 Jun; 36(6):462-4. PubMed ID: 7314017 [TBL] [Abstract][Full Text] [Related]